标题
Cholesterol-Lowering Agents
作者
关键词
-
出版物
CIRCULATION RESEARCH
Volume 124, Issue 3, Pages 354-363
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-02-01
DOI
10.1161/circresaha.118.313245
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
- (2018) Isao Taguchi et al. CIRCULATION
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
- (2018) François Mach et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2016) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular DiseaseCLINICAL PERSPECTIVE
- (2016) George Thanassoulis et al. CIRCULATION
- Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia PhenotypeClinical Perspective
- (2016) Amanda M. Perak et al. CIRCULATION
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population
- (2016) Jamal S. Rana et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- Familial hypercholesterolaemia: A global call to arms
- (2015) Antonio J. Vallejo-Vaz et al. ATHEROSCLEROSIS
- The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
- (2015) David Preiss et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort
- (2014) Maryam Kavousi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient
- (2014) Christoph Wanner et al. KIDNEY INTERNATIONAL
- Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study
- (2014) Sune F Nielsen et al. Lancet Diabetes & Endocrinology
- Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
- (2013) Warner M. Mampuya et al. AMERICAN HEART JOURNAL
- Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
- (2013) Mark J. Pletcher ANNALS OF INTERNAL MEDICINE
- Discontinuation of Statins in Routine Care Settings
- (2013) Huabing Zhang et al. ANNALS OF INTERNAL MEDICINE
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease
- (2013) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?
- (2011) Anne Holbrook et al. CANADIAN JOURNAL OF CARDIOLOGY
- Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era
- (2011) Lawrence D. Lazar et al. CIRCULATION
- Statins and Intracerebral Hemorrhage
- (2011) Daniel G. Hackam et al. CIRCULATION
- Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin
- (2011) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- A historical perspective on the discovery of statins
- (2010) Akira ENDO PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)
- (2009) John C. LaRosa et al. AMERICAN JOURNAL OF CARDIOLOGY
- Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes
- (2009) Sabina A. Murphy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Total Cardiovascular Disease Burden: Comparing Intensive With Moderate Statin Therapy
- (2009) Matti J. Tikkanen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
- (2008) A. Neil et al. EUROPEAN HEART JOURNAL
- Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?
- (2008) A J Kerr et al. HEART
- Prevalence of Musculoskeletal Pain and Statin Use
- (2008) Catherine Buettner et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started